International Psoriasis Council
Advancing Knowledge. Enhancing Care.
IPC Europe Virtual Masterclass
Course Overview
The IPC Virtual Psoriasis Masterclass is designed for dermatologists who are making treatment decisions and managing patients with psoriasis and are interested in specializing in psoriasis.
Over the five days of the course, IPC’s world-renowned experts will cover a variety of topics including the pathogenesis of psoriasis, new and emerging therapies and how to be an advocate for your patient.
The Masterclass agenda has been carefully developed to provide knowledge for daily use to the practicing dermatologist in an intimate environment designed to maximize faculty/participant interactions. Through lectures, panels, case-based discussions and question-answer sessions, attendees will obtain practical and important information for their clinical practice.
The IPC Masterclass is open to dermatologists who meet the following criteria:
- A diploma, 1st part MSc or higher degree in internal medicine or dermatology
- Practicing internal medicine or dermatology within a governmental establishment i.e. university hospital, public hospitals, rural hospitals, etc.
- At least 3 years of dermatology practice
- General practitioners or dermatologists interested in psoriasis and who see at least two case of psoriasis per week
The IPC Virtual Psoriasis Masterclass, Sessions 1-5, Virtual, Romania, have been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 10 European CME credits (ECMEC®s)*. Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity. For full details, please see the EACCME Accreditation Statements.
*Each of five sessions is accredited with 2 ECMEC®s.
There is no cost to attend the program, but space is limited. The application deadline is September 22, 2022.
Timezones:
Hungary/Poland/Serbia Time: 2:00-4:00 pm
Bulgaria/Greece/Romania Time: 3:00-5:00 pm
Agendas
Session 1 – Thursday, October 6
WELCOME + INTRODUCTION
George Sorin Tiplica
Psoriasis: From Pathophysiology to Targeted Therapy
Wolf Henning Boehncke
Phenotypes of Psoriasis
Peter van de Kerkhof
Comorbidities of Psoriasis
Luigi Naldi
Psoriasis: Treat to Target
Ulrich Mrowietz
CLOSING COMMENTS
Lluís Puig
Session 2 – Thursday, October 13
WELCOME + INTRODUCTION
Lluís Puig
Psoriasis: Assessment of Disease Severity in Clinical Practice
Marcus Schmitt-Egenolf
Optimizing Use of Topical Therapy and Conventional Systemic Agents in Psoriasis
Peter van de Kerkhof
Psoriatic Arthritis: Early Diagnosis and Management
Alice Gottlieb
Management of Pustular Psoriasis
Hervé Bachelez
Global Psoriasis Atlas
Darren Ashcroft
CLOSING COMMENTS
George Sorin Tiplica
Session 3 – Thursday, October 20
WELCOME + INTRODUCTION
George-Sorin Tiplica
Psoriasis in Special Areas (Palms and Soles, Nails, Scalp, Genital Areas)
George-Sorin Tiplica
Management of Erythrodermic Psoriasis
Deepak Balak
Role of Phototherapy in the Management of Psoriasis
Mohamed El-Komy
Lifestyle & Psoriasis
Jörg Prinz
Optimizing the Use of Biologics and Biosimilars in Psoriasis
Arnon Cohen
CLOSING COMMENTS
Lluís Puig
Session 4 – Thursday, October 27
WELCOME + INTRODUCTION
George-Sorin Tiplica
Management of Psoriasis in Children
Carmen Salavastru
Management of Psoriasis in Pregnant and Breastfeeding Women
Mahira Hamdy El Sayed
CHALLENGING PSORIASIS CASE WORKSHOP – FACULTY
Case 1: Recalcitrant Psoriasis in Obesity
Adelina Sendrea
Case 2: Psoriasis with Hep B
TBD
Case 3: Patients with Strong FH of Malignancy, Personal History of Lymphoma or Breast Cancers
Marijana Vičić
Case 4: Patient with Tuberculosis and Psoriasis
Filip Rob
CLOSING COMMENTS
Lluís Puig
Session 5 – Thursday, November 3
WELCOME + INTRODUCTION
Lluís Puig
Impact of the COVID-19 Pandemic on Management of Psoriasis; Role of Teledermatology
Alba Català
New and Emerging Therapy for Psoriasis
Lluís Puig
Role of Patient Support Groups in Psoriasis
Josef de Guzman
CHALLENGING PSORIASIS CASE WORKSHOP – PRESENTED BY DELEGATES
CLOSING COMMENTS
George-Sorin Tiplica and Lluís Puig
Hervé Bachelez, MD, PhD
Hôpital Saint-Louis, Imagine Institute for Human Genetic Diseases, University of Paris
Paris, France
IPC Vice President/President Elect
Bio
Deepak Balak, MD, PhD, MSc
LangeLand Hospital and Ghent University Hospital
Zoetermeer, Netherlands
Bio
Arnon Cohen, MD, MPH, PhD
Clalit Health Services, Department of Quality Measures and Research
Tel Aviv, Israel
Bio
Luigi Naldi, MD
AULSS 8, Ospedale San Bortolo, Vicenza, Centro Studi GISED, Bergamo
Vicenza and Bergamo, Italy
Bio
